Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Jill Clark

Colon & Rectal Surgery Albuquerque, NM Medical Doctor

NPI 1295922052 CMS profile 286218

715 Dr Martin Luther King Jr Ave Ne Ste 301, Albuquerque, NM 87102

Open in the dashboard

General payments

$5,742

32 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Jill Clark of Albuquerque, NM is reported in the CMS Open Payments database as having received $5,742 across 32 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 65th percentile of Colon & Rectal Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,674 14
2023 General $67 2
2022 General $3,789 9
2020 General $49 3
2019 General $162 4

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jill Clark
  • Colon & Rectal Surgery median
  • Middle half of Colon & Rectal Surgery
  • National median

In program year 2025, general payments to Jill Clark were reported at $1,674. Among 1,481 Colon & Rectal Surgery profiles paid that year, the median was $317 and the middle half received between $109 and $1,248.

Show as a table
Year Jill Clark Colon & Rectal Surgery median Middle half National median
2019 $162 $443 $125–$2,179 $163
2020 $49 $167 $53–$931 $114
2021 $0 $207 $72–$1,272 $132
2022 $3,789 $341 $111–$1,587 $149
2023 $67 $322 $115–$1,420 $160
2024 $0 $328 $112–$1,354 $164
2025 $1,674 $317 $109–$1,248 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Intuitive Surgical, Inc. $4,868 14 payments
  2. AbbVie, Inc. $334 4 payments
  3. Medtronic, Inc. $150 1 payment
  4. Allergan Inc. $127 2 payments
  5. Ethicon US, LLC $116 3 payments
  6. Boston Scientific Corporation $28 1 payment
  7. Reprise Biomedical, Inc. $28 2 payments
  8. Smith+Nephew, Inc. $27 1 payment
  9. Vioptix Inc $21 1 payment
  10. Vertex Pharmaceuticals Incorporated $15 1 payment
  11. Other $29 2 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Education $2,500 1 payment
  2. Travel and Lodging $1,685 6 payments
  3. Food and Beverage $1,557 25 payments
Products named General payments · program years 2019–2025
  1. DAVINCI XI $2,500 1 payment
  2. Da Vinci Surgical System $2,368 13 payments
  3. INTERSTIM $150 1 payment
  4. STRATTICE $127 2 payments
  5. NATRELLE SALINE-FILLED BREAST IMPLANTS $122 1 payment
  6. SURGICEL NU-KNIT $89 1 payment
  7. STRATAFIX $89 1 payment
  8. STRATTICE RECONSTRUCTIVE TISSUE MATRIX BPS $77 2 payments
  9. MIRO3D $28 2 payments
  10. GRAFIX PL $27 1 payment
  11. Other $83 6 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

32 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Colon & Rectal Surgery in New Mexico

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record